DE602005017194D1 - Verfahren zur herstellung von carvedilol und seinen enantiomeren - Google Patents

Verfahren zur herstellung von carvedilol und seinen enantiomeren

Info

Publication number
DE602005017194D1
DE602005017194D1 DE602005017194T DE602005017194T DE602005017194D1 DE 602005017194 D1 DE602005017194 D1 DE 602005017194D1 DE 602005017194 T DE602005017194 T DE 602005017194T DE 602005017194 T DE602005017194 T DE 602005017194T DE 602005017194 D1 DE602005017194 D1 DE 602005017194D1
Authority
DE
Germany
Prior art keywords
carvedilol
preparation
enantiomer
enantiomers
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017194T
Other languages
English (en)
Inventor
Guixer Elisenda Trepat
Alvarez Anna Munoz
Marco Marta Pomares
Olondriz Francisco Marquillas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zach System SpA
Original Assignee
Zach System SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zach System SpA filed Critical Zach System SpA
Publication of DE602005017194D1 publication Critical patent/DE602005017194D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005017194T 2004-12-09 2005-12-05 Verfahren zur herstellung von carvedilol und seinen enantiomeren Active DE602005017194D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106438 2004-12-09
PCT/EP2005/056469 WO2006061364A1 (en) 2004-12-09 2005-12-05 Process for the preparation of carvedilol and its enantiomers

Publications (1)

Publication Number Publication Date
DE602005017194D1 true DE602005017194D1 (de) 2009-11-26

Family

ID=35985349

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017194T Active DE602005017194D1 (de) 2004-12-09 2005-12-05 Verfahren zur herstellung von carvedilol und seinen enantiomeren

Country Status (16)

Country Link
US (2) US20090005429A1 (de)
EP (1) EP1838670B1 (de)
JP (1) JP2008523025A (de)
CN (1) CN100591668C (de)
AT (1) ATE445601T1 (de)
CA (1) CA2589699A1 (de)
CY (1) CY1110688T1 (de)
DE (1) DE602005017194D1 (de)
DK (1) DK1838670T3 (de)
ES (1) ES2333537T3 (de)
HR (1) HRP20100023T1 (de)
IL (1) IL183449A0 (de)
PL (1) PL1838670T3 (de)
PT (1) PT1838670E (de)
SI (1) SI1838670T1 (de)
WO (1) WO2006061364A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000216A1 (en) 2000-06-28 2002-01-03 Teva Pharmaceutical Industries Ltd. Carvedilol
US6710184B2 (en) 2002-01-15 2004-03-23 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
KR100746455B1 (ko) * 2006-02-23 2007-08-03 안국약품 주식회사 고광학순도의 키랄 카베딜롤의 제조방법
US8022094B2 (en) 2006-06-28 2011-09-20 Teva Pharmaceutical Industries Ltd. Carvedilol phosphate
CN102190613B (zh) * 2010-03-14 2014-06-25 浙江华海药业股份有限公司 一种卡维地洛的制备方法
DK2549871T3 (en) 2010-03-23 2018-12-10 Siga Tech Inc Polymorphic form ST-246 and processes for its preparation
WO2015031914A1 (en) * 2013-08-30 2015-03-05 Uti Limited Partnership Store overload-induced calcium release inhibitors and methods for producing and using the same
CN104592096A (zh) * 2014-12-24 2015-05-06 江苏苏南药业实业有限公司 一种s-卡维地洛的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
EP0893440A1 (de) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Eine thermodynamisch stabile Modifikation von 1-(4-Carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, Verfahren zu ihrer Herstellung und ihre enthaltende Arznemittel
WO2002000216A1 (en) * 2000-06-28 2002-01-03 Teva Pharmaceutical Industries Ltd. Carvedilol

Also Published As

Publication number Publication date
PL1838670T3 (pl) 2010-03-31
CY1110688T1 (el) 2015-06-10
US20120041044A1 (en) 2012-02-16
CA2589699A1 (en) 2006-06-15
CN101072753A (zh) 2007-11-14
HRP20100023T1 (hr) 2010-02-28
EP1838670B1 (de) 2009-10-14
EP1838670A1 (de) 2007-10-03
US20090005429A1 (en) 2009-01-01
WO2006061364A1 (en) 2006-06-15
SI1838670T1 (sl) 2010-04-30
CN100591668C (zh) 2010-02-24
IL183449A0 (en) 2007-09-20
JP2008523025A (ja) 2008-07-03
ES2333537T3 (es) 2010-02-23
PT1838670E (pt) 2009-12-18
ATE445601T1 (de) 2009-10-15
DK1838670T3 (da) 2010-03-01

Similar Documents

Publication Publication Date Title
DE602005017194D1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren
ATE520656T1 (de) Verfahren zur herstellung von 2-oxo-1- pyrrolidinderivaten
MA31858B1 (fr) N-phenyl-bipyrrolidine-carboxamides substitues et utilisation therapeutique de ceux-ci
CO6190616A2 (es) Carboxamidas n-fenil-bipirrolidina sustituidas y su uso terapeutico
DE602006003320D1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
DE602006017918D1 (de) Verfahren zur Herstellung von Telmisartan
MA31889B1 (fr) N-phenyl -bipyrrolidine-urees substituees et utilisation therapeutique de celles-ci
DE602005018238D1 (de) Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel
ATE503767T1 (de) Herstellung eines von willenbrand faktor- präparates mit hoher spezifischer aktivität
DE50305771D1 (de) Verfahren zur herstellung von (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE602005004557D1 (de) Verfahren zur herstellung von mycophenolat-mofetil mittels enzymatischer umesterung
DE502007003046D1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy-2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
DE602005013681D1 (de) Verfahren zur herstellung von escitalopram
ATE464289T1 (de) Neues verfahren zur herstellung von thoc
DE50300920D1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
ATE318815T1 (de) Verfahren zur herstellung von enantiomeren von indol-2,3-dion-3-oximderivaten
DE502006004222D1 (de) Verfahren zur Herstellung von hochreinem, halogenfreien o-Phthalaldehyd
ATE546451T1 (de) Cyclopropancarbonsäureester von acyclovir
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
DE602006020238D1 (de) Optisch aktiven Cyclopentenonen zur Herstellung von Prostaglandinen
ATE556054T1 (de) Verfahren zur herstellung von loperamid
DE502006005580D1 (de) Verfahren zur herstellung von optisch aktiven 3-phenylpropionsäurederivaten und folgeprodukte davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition